Literature DB >> 16609298

Epidemiology of non-dialysis-requiring chronic kidney disease and cardiovascular disease.

Alan S Go1, Joan C Lo.   

Abstract

PURPOSE OF REVIEW: To review recent literature about the relationship between non-dialysis-requiring chronic kidney disease and cardiovascular disease as well as possible explanatory factors. RECENT
FINDINGS: Reduced estimated glomerular filtration rate below 60 ml/min/1.73 m independently predicts the risk of death and cardiovascular events in persons with or without known cardiovascular disease as well as those undergoing coronary or peripheral arterial revascularization. This risk is not linearly associated with level of kidney function. Chronic kidney disease is associated with a larger burden of traditional vascular risk factors but is also linked to abnormalities in a variety of nontraditional pathways such as dysregulation of mineral metabolism and arterial calcification, vessel stiffness and endothelial dysfunction, insulin resistance, inflammation, malnutrition, and anemia, among others. Other novel kidney-specific proteins (e.g. renalase) may play direct mediating roles. The relative contribution of these factors to excess cardiovascular disease in chronic kidney disease remains unclear.
SUMMARY: Recent evidence demonstrates the importance of non-dialysis-requiring chronic kidney disease as a potent predictor of cardiovascular disease and its complications. Randomized trials should be performed to determine whether modification of traditional and nontraditional risk factors can reduce incident cardiovascular disease as well as which interventions can optimize treatment outcomes in persons with chronic kidney disease and cardiovascular disease.

Entities:  

Mesh:

Year:  2006        PMID: 16609298     DOI: 10.1097/01.mnh.0000222698.30207.aa

Source DB:  PubMed          Journal:  Curr Opin Nephrol Hypertens        ISSN: 1062-4821            Impact factor:   2.894


  6 in total

Review 1.  Novel insights into the physiology of renalase and its role in hypertension and heart disease.

Authors:  Gary Desir
Journal:  Pediatr Nephrol       Date:  2011-03-20       Impact factor: 3.714

2.  Chronic kidney disease.

Authors:  Simon de Lusignan
Journal:  Br J Gen Pract       Date:  2006-11       Impact factor: 5.386

Review 3.  Fibroblast growth factor 23 and adverse clinical outcomes in chronic kidney disease.

Authors:  Tamara Isakova
Journal:  Curr Opin Nephrol Hypertens       Date:  2012-05       Impact factor: 2.894

4.  Central pulse pressure in chronic kidney disease: a chronic renal insufficiency cohort ancillary study.

Authors:  Raymond R Townsend; Julio A Chirinos; Afshin Parsa; Matthew A Weir; Stephen M Sozio; James P Lash; Jing Chen; Susan P Steigerwalt; Alan S Go; Chi-Yuan Hsu; Mohammed Rafey; Jackson T Wright; Mark J Duckworth; Crystal A Gadegbeku; Marshall P Joffe
Journal:  Hypertension       Date:  2010-07-26       Impact factor: 10.190

5.  Disorders of lipid metabolism and chronic kidney disease in the elderly.

Authors:  Devasmita Choudhury; Meryem Tuncel; Moshe Levi
Journal:  Semin Nephrol       Date:  2009-11       Impact factor: 5.299

6.  Serum renalase is related to catecholamine levels and renal function.

Authors:  Feng Wang; Junhui Li; Tao Xing; Yuting Xie; Niansong Wang
Journal:  Clin Exp Nephrol       Date:  2014-03-04       Impact factor: 2.801

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.